Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
SYRS

SYRS - Syros Pharmaceuticals Inc Stock Price, Fair Value and News

6.00USD+0.02 (+0.33%)Market Closed

Latest Insider Trading transactions for SYRS

Datesorted ascendingNameBuy/Sell$ Value# SharesAvg. PriceTitle
2024-06-28 Premium
sold
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-05 Premium
acquired
Premium Premium Premium-
2024-06-01 Premium
acquired
Premium Premium Premium-
2024-06-01 Premium
acquired
Premium Premium Premium-
2024-04-03 Premium
sold
Premium Premium PremiumChief Medical Officer
2024-04-02 Premium
sold
Premium Premium PremiumChief Medical Officer
2024-04-01 Premium
sold (taxes)
Premium Premium PremiumChief Financial Officer
2024-04-01 Premium
sold (taxes)
Premium Premium PremiumPresident & CEO
2024-04-01 Premium
sold (taxes)
Premium Premium PremiumChief Development Officer
2024-04-01 Premium
sold (taxes)
Premium Premium PremiumChief Medical Officer
2024-04-01 Premium
sold (taxes)
Premium Premium Premium-
2024-03-31 Premium
acquired
Premium Premium PremiumChief Financial Officer
2024-03-31 Premium
acquired
Premium Premium PremiumPresident & CEO
2024-03-31 Premium
acquired
Premium Premium PremiumChief Development Officer
2024-03-31 Premium
acquired
Premium Premium PremiumChief Medical Officer
2024-03-31 Premium
acquired
Premium Premium Premium-
2024-03-28 Premium
sold (taxes)
Premium Premium PremiumChief Legal & Compliance Offic
2024-03-27 Premium
acquired
Premium Premium PremiumChief Legal & Compliance Offic
2023-12-21 Premium
bought
Premium Premium Premium-

Rows per page:

1–25 of 50